Late Life Depression
13
1
2
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
23%
3 trials in Phase 3/4
33%
2 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (13)
Dopaminergic Dysfunction in Late-Life Depression
RCT of Brain Longitudinal Biomarker Study (OPT-Neuro RCT)
Chronic Anergic Depression IDentification - Magnetic Resonance Imaging Exploration in the Elderly of Traits Related to Onset
Optimizing Outcomes of Treatment-Resistant Depression in Older Adults
TBS,TMS, Suicidal Ideation, Magnetic Resonance Imaging, Dorsolateral Prefrontal Cortex, Ventrolateral Prefrontal Cortex
One-Year Trajectory of Cognitive Changes in Patients With Late-life Depression in the Short Term
Exploration of the Potential Mechanisms of n-3 Fatty Acids Supplementation in Depression and Cognitive Function in Patients With Late-life Depression
Ketamine for Older Adults Pilot
Explore the Neural Mechanism of Mindfulness Training to Reduce Loneliness in Depressed Older Adults
SSIPP vs. PST vs. WLC
CM Delivered PST in LLD Pilot
A Breathing-Based Meditation Intervention for Patients With Treatment Resistant Late Life Depression
Automatic Self Transcending Meditation (ASTM) Versus Heart Rate Variability (HRV) Biofeedback in Patients With Late Life Depression (LLD): a Longitudinal Pilot Feasibility Study